• Not-so-shared cancer decision-making

    In my cancer care so far, shared decision-making between doctor and patient is only half-working. In this post, I ask why.

    Shared decision-making occurs in medicine when physicians help patients make choices that cohere with both the patient’s values and the best scientific evidence. In my previous cancer post, I described how I had to choose whether to be treated only with radiotherapy or to have radiation with concurrent chemotherapy. In choosing to have radiation-only — that is, no chemotherapy — I was helped by several physicians at the Ottawa Hospital. They answered my questions clearly and respectfully. Interestingly, my doctors disagreed about what I should do, and I was pleased that they were candid about that. Friends and family members in medicine also helped. I am particularly grateful to several physicians and cancer survivors, compassionate strangers who read my posts and wrote to me. Thanks to you all.

    So when I think about these interactions, shared decision-making worked superbly for me. I will continue to say this even if the treatment fails because this aspect of the caregiving has been excellent, regardless of the (to-be-determined) outcome.

    Except that none of these wonderful interactions matter if the health care system can’t process even simple communications from a patient.

    On July 27, I got a call from the radiation clinic, telling me that my first radiation session would be on the 29th. Which is lovely, because I want to fry this tumour’s ass before it has further chance to spread. But a few minutes after I hung up, the chemotherapy clinic called to tell me about my first chemotherapy session.

    Me: “Sorry, but I thought that I was clear that I had elected not to have chemotherapy.”

    Clerk: “No, we have an order for you to start chemotherapy.”

    Me: “Dr. X [the medical oncologist] asked me to decide about chemotherapy and let him know. I communicated that on MyChart.” [MyChart is the application that gives patients a (highly-restricted) view of Epic, the hospital’s electronic health record.]

    Clerk: “You can’t use MyChart for that.” [The clerk was correct. MyChart, at least as implemented here, gives you no means to send a message to a doctor. I had misremembered.] “You have to use the Patient Support Line.” [That was what I had misremembered. I had used the Patient Support Line to get a message to Dr. X, not MyChart.]

    Me: “OK, so can you cancel the appointment?”

    Clerk: “No, you have to use the Patient Support Line.”

    I hung up and called the Patient Support Line, which is a phone robot. When it answered, I recognized its voice, and I recalled that yes, I had called this line to send Dr. X my decision. You might imagine that the Patient Support Line would connect you to a person. Someone who can, you know, support you as a patient? Instead, it’s a barebones phone tree. The Patient Support Line allows you to leave a message, but it’s not clear to me who reads it or what they do with it. Regardless, I once again left my message for Dr. X. So far as I can tell, neither my first nor second message reached Dr. X or anyone who works for him.

    Isn’t this box helpful?

    Next, I opened MyChart, and yes, there are my chemotherapy appointments. OK, great, these are calendar appointments, so there ought to be some way to decline or cancel them, right? No, there is not. Well, then surely there will be a mechanism to mail the person who created the appointment to let them know it is incorrect. If there is, I can’t find it. There is a box that you can check to indicate that the information is correct, but there is no box to note that something is incorrect. The semantics here are puzzling. An unchecked box means either a) the patient ignored this or b) the patient thinks something is wrong. How is that helpful to anyone?

    Stop, I tell myself. Don’t spend your time debugging an application for Ottawa Hospital’s IS Department. Let’s go old skool and telephone the Chemotherapy Program. I look up the number, call them, and tell the clerk my story.

    Clerk: “This is New Patient Registration. This isn’t something we can handle. How did you get this number?”

    Me: “It’s the number that’s listed? Anyway, whom should I call?”

    Clerk: “That’s an excellent question. Please hold.”

    He puts me on hold. A few minutes later, he returns to the call and — this is pure Canada — he is scrupulously polite with just the faintest hint of reproach that, somehow, I haven’t followed The Rules. But — again, pure Canada — he is helpful:

    Clerk: “I’ve sent a message to Dr. X. A nurse will call you to discuss your concerns.”

    I hang up, then realize that I forgot to ask whether that means that the appointment has been cancelled. Cynically, I predict that the next call I get from the chemotherapy office will ask me why I missed my appointment.

    But I was wrong. A nurse calls within an hour.

    Nurse: “What is your question is about your chemotherapy appointment?”

    I tell my story again, and she promises to cancel the appointment. I think the problem is solved.

    The loss of my time aside, I haven’t been harmed by this confusion. No one acted badly at any point, and busy people treated me with commendable patience. But measured against the aspirations of shared decision-making, this was a disaster. What’s the point of having a nuanced and sensitive discussion about values, probabilities, and uncertainty when it takes two weeks and multiple phone calls to communicate a simple “No, I do not want this treatment”?

    I wasn’t harmed because I am a determined son of a bitch a medical school professor, meaning doctors pay me to tell them what they should think. So by personality and status, I don’t have any trouble raising my voice about my care. But I have someone I am close to, who I’ll call “Jim,” who would have been harmed. Jim is a former middle school teacher with a terrifying autoimmune disorder. He has limited mobility and experiences constant, severe pain. He’s frequently hospitalized and has had far too many surgeries. In my opinion, Jim’s care hasn’t been as good as it should be. But he’s not the kind of person who questions his doctors. If the system sent Jim incorrect chemotherapy appointments, he wouldn’t have interpreted it as system noise, as I did. He would have assumed that the doctor had changed her mind, and he would have sucked it up and done what he thought he was being told to do.

    So, what’s the problem with shared decision-making? We imagine that medical care is something that a doctor provides to a patient. Consistent with that view, shared decision-making is presented as an ongoing conversation between a doctor and a patient. See, for example, Dr. Paul Kalanithi’s cancer memoir, in which ‘Emma,’ his empathetic and ‘best-in-world’ oncologist is there for him whenever he needs her. Unfortunately, these views of medical care and shared decision-making miss something important.

    What they miss is that although doctor-patient dyads matter, patients are cared for by systems. Systems are sprawls of often loosely-connected people, linked by communications networks and institutional practices. Care processes must be structured so that doctors and patients can have conversations that facilitate shared decision-making. But that’s not enough. I need to be able to communicate my choices to the system. These choices should reach every relevant person in my care team. Finally, I should be able to monitor what’s happening and flag problems when care deviates from my understanding of the plan.

    This requires (vastly) improved engineering of health information systems. It may also require us to rethink who does what when in the care process. For example, wasn’t the idea that primary care doctors were going to ‘quarterback’ the care process? What happened to that? These are challenging problems, and I don’t fault anyone. But there is so much work to do.


    To read my Cancer Posts from the start, please begin here. The next Cancer Post, on the experience of radiation therapy, is here.

    @Bill_Gardner

     
    item.php
  • Treating cancer: So many decisions

    It’s July 16th, two weeks since the CT scan in the ED revealed the mass in my throat. Canadian medicine has rallied to my side. I have met with a throat surgeon, a radiation oncologist, and a medical oncologist. You know that you are in deep shit trouble when you need to talk to three subspecialists. It’s time to decide about my course of treatment. This post is about how I — or, better, my wife and I — made this decision.

    First, let’s celebrate that the system recognized that it was my choice to decide what treatment I should receive. It wasn’t always so. Nineteenth- and early 20th-century doctors were white males who believed they had the authority to determine how patients would be treated. But starting in the 1960s, bioethicists insisted that this style of practice was inconsistent with respect for patients’ autonomy. Lawyers argued that, for example, removing a cancerous breast while a woman was anesthetized was an assault. That patients have rights to consent and that medical decision-making should be a collaboration between doctors and patients was a revolution — incomplete and imperfect — but much to the benefit of patients.

    What are the choices for treating my cancer? In essentials, they are a) surgery (hence, the throat surgeon), radiation (the radiation oncologist), and chemotherapy (the medical oncologist). I can have all or none of these therapies, so there are 8 options, as you see below.

    All possible treatment combinations.

    To my surprise, however, not even the throat surgeon thought that surgery was a good choice. Yes, it would get the carcinoma out of my throat, but so would a few grams of plastic explosive. A surgeon would have to excise significant portions of my throat and tongue. So if we take the ‘No’ branch, then the choices look like this.

    Ruling out surgery makes things simpler.

    But the next choice is also easy. We must get the tumour out somehow, or it will kill me, and radiation will do that with less trauma than surgery. Radiation disrupts the functioning of the cellular nuclei, killing the cells. Because they are reproducing more quickly, cancerous cells have more active nuclei than healthy cells, and this makes them more vulnerable. This means that radiation is more likely to kill cancerous than healthy cells. So radiation can destroy the tumour while leaving the surrounding tissue injured but structurally intact.

    The difficult choice is whether to have chemo.

    This doesn’t mean that radiation is safe or comfortable. A standard part of the preparation for radiation is an exam from a dental surgeon. He explains that the treatment will kill my salivary glands, giving me a dry mouth. Saliva also prevents tooth decay. Therefore, to keep my teeth, I will have to practice an elaborate daily care routine for the rest of my life. Radiation will also weaken the bone in my jaw. So what? It beats certain death.

    This leaves one more decision: should I have chemotherapy concurrently with my radiation treatment? Chemotherapy — in this case, a drug called cisplatin — is poison. However, it is more poisonous to cancerous cells than to healthy cells. As with radiation, the idea is to give you just enough to kill the cancer cells without killing too many of your healthy cells. Unlike radiation, however, chemotherapy will act throughout my body, not only on the mass in my throat.

    This is a good thing because there is a chance that some cancerous cells may have seeded themselves in other organs of my body. If so, I may eventually have one or more new tumours. Randomized clinical trial data suggest that with radiation + chemo, I will have a higher chance of being alive in five years than with radiation alone. My doctors estimate that I have an 80% 5-year survival probability with radiation alone, and an 85% chance with radiation + chemotherapy. There’s uncertainty about these probabilities. Some of the data are old, and some were collected before the significance of HPV+ tumours was known. Nevertheless, I’m persuaded that radiation + chemo would give me a better chance of surviving.

    But living longer isn’t the only thing I want. Radiation + chemo would be a more gruelling treatment than radiation alone. Worse, chemotherapy can cause permanent harmful side effects. The side effect I fear most is a chemotherapy-induced cognitive impairment (CICI, sometimes called ‘chemo brain’). There is emerging evidence that some (but not all) cancer survivors experience permanent deterioration of their abilities to remember things and solve problems. I am a researcher and writer, and being unable to continue my work would be a painful loss.

    What’s the risk of CICI? Unfortunately, we don’t know because we have much less data on CICI than on cancer survival. For many reasons, cancer specialists have focused more on survival than long-term quality of life. My doctors say that they don’t see CICI in their patients, but is this because it doesn’t happen or because they did not follow-up with their patients to ask about it? My suspicion is that CICI is a bigger problem than most oncologists realize.

    My preference, then, is to have radiation without concurrent chemotherapy. I’ll accept a small reduction in 5-year survival probability for a possible, but unquantifiable improvement in the chance that I will retain my mental acuity post-cancer treatment.

    But am I thinking about this problem the right way? Medical decision making is always framed in terms of the interests and beliefs of an isolated patient. But I am more than just me. I have a spouse, and I’m a parent of 5 children (albeit now grown adults). Trading off a survival risk for a possibly better quality of life seems best to me, but one of my mantras is, “It’s not about you.”

    Kathi and I talk about this at length. Her view is that if she had cancer, she’d do everything possible to be sure to be rid of it. “If it was in my body, I wouldn’t be able to think about anything else. But that’s not you at all.” She’s right. Even having seen the tumour, I think about it only when I get a twinge of pain in that region. It’s just another hassle, not something I’m anxious about. I ask, “If I don’t take the maximum treatment, won’t you constantly worry that it is still in me?” “You might think so, but I don’t think I will. And I know how much you would regret it if you could no longer write.” So, we’ll go with radiation only.


    To read the Cancer Posts from the start, please begin here. The next post, about shared decision-making, is here.

    @Bill_Gardner

     
    item.php
  • Chapter 2. Playing for real money. In which I meet my tumour

    On July 9th, I spent the day at the Cancer Centre meeting with my radiation oncologist, and I learned a lot. I’ll tell you about my cancer, what might have caused it, and what that tells us about how we can prevent cancers like this.

    My cancer is an ~80 cubic centimetres, p16 positive, oropharyngeal, squamous cell carcinoma (p16+ OPSCC). Carcinoma means that this cancer originated from epithelial cells. Epithelial cells form the surface of your throat and mouth. Squamous cell indicates the type of epithelial cells; squamous cells are flat, like tiles or plates. Oropharyngeal tells us that the carcinoma is in the middle of my throat. P16+ means that when the pathologist stained the biopsy sample in a certain way, it revealed that a high-risk variant of the human papillomavirus (HPV) helped cause this cancer. 80 cc ( = ~5 inches3) indicates that the carcinoma is, unfortunately, large.

    The radiation oncologist inserted a thin tube with a camera and an LED into my nostril and threaded it down into my mouth. This felt weird, but not painful. The camera showed us the inside of my throat. And there was the tumour: an irregularly surfaced lump, vast on a big screen.

    Radiation oncologist: “That’s why you can’t swallow well. I’m amazed that the air can get around it. Actually, how do you even breathe?”

    <Me: [silent] Like I’m supposed to know?>

    RO: “If your throat swells from the radiation, you won’t be able to breathe. Maybe we’ll need to do a tracheotomy before we start.”

    <Me: [silent, but SHOUTING] SAY WHAT?>

    If it wasn’t clear already, this game is played for real money.

    So what caused this cancer? Tobacco and alcohol are the principal risk factors for throat and mouth cancers, but I have never smoked, and I don’t drink that much.

    However, the staining of the biopsy sample showed that I was at some time infected with a strain of HPV that can cause this type of cancer (not all strains do). HPV can cause cancer not only in the pharynx but also in the cervix, vulva, vagina, penis, or anus. In the US in 2019, there were 52,840 new cases of these cancers and 12,100 deaths.

    So how does HPV cause cancer? When a virus infects a cell, the genes in the virus use materials in the cell to make proteins that eventually replicate the virus. However, these proteins can have additional consequences. In the dangerous strains of HPV, we call some of the viral genes oncogenes, because they influence the cell to transition to unrestrained growth, that is, cancer.

    How HPV infection can lead to throat cancer. From Liu et al., The molecular mechanisms of increased radiosensitivity of HPV-positive oropharyngeal squamous cell carcinoma (OPSCC): an extensive review. J Otolaryngol – Head Neck Surg 2018;47:59. Available from: https://doi.org/10.1186/s40463-018-0302-y

    The HPV oncogenes produce oncoproteins, in this case, the E6 and E7 oncoproteins. The oncoprotein E7 leads to a cascade of events, one of which is the overproduction of the p16 protein. When the pathologist stained my biopsy sample, the overproduction of p16 became visible, and he or she used this marker to diagnose the carcinoma as HPV+ ( = p16+). E7 also damages the brakes on the cell reproduction cycle, which helped set the stage for uncontrolled proliferation.

    The E6 oncoprotein interferes with the action of the p53 protein, a famous molecule that is essential in DNA repair. P53 is also critical to safety mechanisms in cells that trigger apoptosis — cell death — when dangerous problems develop in cell reproduction. E6 also helps preserve telomere length in the cell’s chromosomes. Diminishing telomere lengths are part of the cellular ageing processes. By keeping them long, E6 helps make the cell immortal.

    The transition from healthy to cancerous cells takes a long time following HPV infection.  Nevertheless, the upshot of these sequences of events is that the cell becomes long-lived, and it reproduces in an uncontrolled way, which is to say it becomes an HPV+ OPSCC, like the tumour I saw on the screen.

    But how, you ask, did I get infected with HPV in the first place? Let’s not be coy:

    Human papilloma viruses are… spread through vaginal, oral and anal sex. HPV is the most common sexually transmitted infection in the United States, affecting more than half of sexually active individuals at some point during their lives… The time lag between an oral HPV infection and the development of HPV-related oropharyngeal cancer is estimated at between 15 and 30 years. As such, the rise in [OPSCC] seen since the 1990s in large part reflects changes in sexual practices in the 1960s and 1970s.

    I was infected as part of a viral epidemic. It most likely happened while I was giving oral sex during college.

    I regret nothing. Tell it like it is, Edith!

    Be advised that the HPV epidemic has never gone away. However, HPV+ OPSCC and cancers of the penis, anus, vulva, vagina are preventable with HPV vaccines. Cervical cancer — the biggest killer — is almost entirely preventable. The vaccines are cost-effective and exceptionally safe. Sixty-seven million doses were administered from 2006 to 2014. Those doses resulted in 25,000 reports of adverse events (< 4 per 10,000 doses). However, only 8% of those reports were serious (~3 in 100,000 doses). Importantly, a report of an adverse event just means that it happened; it does not necessarily mean that the vaccination caused that event. For example, the serious adverse events included 85 deaths, but the deaths had no typical pattern, as would be expected if the vaccine caused them.

    Nevertheless, in 2013, less than 40% of female patients and less than 15% of male patients had been vaccinated. There are at least two reasons. First, there has been political resistance to HPV vaccination.

    Vaccine coverage is hindered by public perceptions regarding HPV’s status as a sexually transmitted infection and dissent over the recommended age of vaccination. Social conservatives have countered vaccine mandates with the argument that they infringe upon parental rights to discuss the topic of sex on their own terms. Pro-abstinence activists raise similar concerns that HPV vaccination may increase teenage promiscuity, though there is no evidence for this claim… Finally, several studies have shown that parents fail to vaccinate due to misperceptions about the risk of HPV infection.

    Some of these misperceptions about vaccine risk stem from false claims spread by Michelle Bachman during her failed presidential campaign in 2011.

    The second reason relatively few youths are vaccinated is that getting vaccinated is a bother. It requires three shots to prevent an adverse health outcome that won’t occur, if it ever does, for decades. That feels, I imagine, like too much trouble.

    We need to cultivate the norm that there is a duty, part of our solidarity with our neighbours, that we should endure the mild risks and inconveniences and get vaccinated for HPV. We could save even more lives by accepting a collective duty to get vaccinated for the flu, and, we must hope, soon for the coronavirus. Doing these things would save many tens of thousands of lives each year.


    To read the Cancer Posts from the start, please begin here. The next post, about how we decided on a treatment, is here.

    @Bill_Gardner

     
    item.php
  • Healthcare Triage Podcast: CAR T-Cell Therapy and the Future of Cancer Treatment

    Aaron Carroll talks to Dr. Sherif Farag of Indiana University about his work harnessing the power of patients’ own immune systems to treat blood cancers like multiple myeloma.

     

    The Healthcare Triage podcast is sponsored by Indiana University School of Medicine whose mission is to advance health in the state of Indiana and beyond by promoting innovation and excellence in education, research and patient care.

    IU School of Medicine is leading Indiana University’s first grand challenge, the Precision Health Initiative, with bold goals to cure multiple myeloma, triple negative breast cancer and childhood sarcoma and prevent type 2 diabetes and Alzheimer’s disease.

    Available wherever you get your podcasts! Including iTunes

    @DrTiff_

     
    item.php
  • Is Hair Dye Linked to Breast Cancer?

    A study published in the International Journal of Cancer reports that use of hair dyes and chemical straighteners, particularly among black women, is associated with a higher risk of breast cancer. We look into this a little more.

     

    @DrTiff_

     
    item.php
  • More Bad Nutrition Studies: Red Meat and Cancer

    The old chestnut that eating red meat leads to cancer is back. A study last week claimed that eating red meat increased cancer risks by up to 28 percent! That sounds scary, but this study has a lot of problems.

     

    @DrTiff_

     
    item.php
  • Healthcare Triage: Sunscreen Needs Some Safety Evaluation

    Skin cancer is a big problem. Sunscreen can help protect your skin. All this is very well known. It turns out, though, that the active ingredients in sunscreen can get into peoples’ bloodstreams in pretty high concentrations. And the effects of sunscreen on the environment isn’t well studied. While sunscreen probably is safe for human use, and might be bad for the environment, we should still look closely at the products we’re using to protect ourselves.

    This episode was adapted from a column I wrote for The Upshot. Links to sources can be found there.

    @aaronecarroll

     
    item.php
  • How Safe Is Sunscreen?

    The following originally appeared on The Upshot (copyright 2019, The New York Times Company). 

    Skin cancer is the most common malignancy in the United States, affecting more than three million people each year. Using sunscreen is one mainstay of prevention. But the recent news that sunscreen ingredients can soak into your bloodstream has caused concern.

    Later this year, the Food and Drug Administration will offer some official guidance on the safety of such ingredients. What should people do in the interim as summer approaches?

    The only proven health risk so far is too much sun exposure. Some may think covering up and limiting time in the sun is important only for those with lighter skin, but the recommendations against UV exposure apply to everyone.

    Yes, you should probably keep using sunscreen, although some who may want to play it extra safe could switch to sunscreens that contain zinc oxide and titanium dioxide.

    Sunscreens were first regulated by the F.D.A. in the 1970s, and they were considered over-the-counter medications, before current American guidelines for the evaluation of drugs were put in place. Because of this, sunscreens didn’t undergo testing the way modern pharmaceuticals would.

    In Europe, things are even more lax. Sunscreens are regulated as cosmetics, and because of this, many more sunscreens are approved there than in the United States.

    The F.D.A., however, has wanted to know: To what degree are chemicals applied to the skin absorbed into the body, and what are the possible effects of those chemicals?

    We now have information about the first question. A few weeks ago, a study was published in JAMA that randomly assigned 24 healthy people to one of four sunscreens. Two of them were sprays, the third was a lotion, and the fourth was a cream. Participants were instructed to apply the sunscreens to 75 percent of their bodies four times a day for four days, and 30 blood samples were drawn over a week.

    The F.D.A.’s guidance says that any active ingredient that achieves systemic absorption greater than 0.5 nanograms per milliliter of blood should undergo a toxicology assessment to see if it causes “cancer, birth defects or other adverse effects.”

    The study examined four common sunscreen components: avobenzone, oxybenzone, octocrylene and ecamsule. For all four, systemic concentrations passed the nanogram threshold after the applications on the first day of the study. The levels were higher than the limit for the entire week for all the products except the cream.

    They also increased from Day 1 to Day 4, meaning that there was accumulation of the chemical in the body with continued use.

    This is not evidence that sunscreens are harmful. It’s entirely possible that the amounts absorbed are completely safe. In fact, given the widespread use of sunscreen, and the lack of any data showing increases in problems related to them, it probably is safe. Sunscreens are a key component of preventing skin damage that can lead to skin cancer.

    But this doesn’t mean the effects of absorption shouldn’t be checked. The F.D.A. is preparing a final recommendation. For now, the proposed rule, which is still open for public comment, suggests that sunscreens with para-aminobenzoic acid (an association with allergies) and trolamine salicylate (an association with bleeding) should not be given the designation “generally regarded as safe and effective.”

    The rule also proposes that sunscreens that rely on zinc oxide and/or titanium dioxide should be “generally regarded as safe and effective.” These inorganic compounds are not absorbed into the body, and sit on the skin reflecting or absorbing the sun’s harmful rays.

    Because they aren’t absorbed, they’re also noticeable. Most people prefer sunscreens that are absorbed. Lots of parents in particular prefer sprays because they’re easier and faster to apply to children, who weren’t even part of this study.

    In recent years, vacation destinations like Hawaii, Palau and Key West have started to ban sunscreens with many organic ingredients because they may be damaging coral reefs. Those ingredients include oxybenzone, octinoxate and parabens.

    These products can accumulate in living organisms over time, in both vacationing humans and sea creatures. Significant doses collect when tens of thousands of people wear sunscreen while swimming in the ocean. These quantities only increase when we wash them off in showers and baths into water that eventually finds its way into the ocean.

    The International Coral Reef Initiative says that more research is necessary, but that while we wait for such work to happen, we should be careful. A review in the Journal of the American Academy of Dermatology agrees, but points out that most studies have been limited to the lab. Many have argued that we should shift to safer “reef-friendly” products.

    It’s not clear, though, that sunscreens containing inorganic ingredients are good for the environment either. A study last yearpointed to the fact that zinc oxide and titanium dioxide could also have bleaching effects on corals.

    When it comes to personal health, a basic plan to cover up seems sensible. I wear a UV protective swim shirt and hat in the sun. My children tell me I don’t look as cool as the other dads, but I need to use a lot less sunscreen than they do. That not only makes my life easier, but it might help the environment, too.

    @aaronecarroll

     
    item.php
  • Healthcare Triage: The Caregiver Gap

    The US healthcare system has a huge gap. A lot of caregiving isn’t covered, and it falls on families and friends to pick up the slack. It can take a lot of time and help to make it through an illness, and there isn’t much coverage for that assistance. We look at several patient experiences with serious illness and the toll it takes.

    This episode was adapted from a column I wrote for the Upshot. Links to sources can be found there.

    @aaronecarroll

     
    item.php
  • Healthcare Triage Podcast: Multiple Myeloma, Bicycles, and Working Toward a Cure

    This month, Aaron is talking to Dr. Rafat Abonour about multiple myeloma. Multiple myeloma is a cancer that forms in white blood cells, and Dr. Abonour tells Aaron about how the disease affects patients, and the cutting edge of research into treatments. And we get a nice story about biking.

    The Healthcare Triage podcast is sponsored by Indiana University School of Medicine whose mission is to advance health in the state of Indiana and beyond by promoting innovation and excellence in education, research and patient care.

    IU School of Medicine is leading Indiana University’s first grand challenge, the Precision Health Initiative, with bold goals to cure multiple myeloma, triple negative breast cancer and childhood sarcoma and prevent type 2 diabetes and Alzheimer’s disease.

    As always, you can find the podcast in all the usual places, like iTunes and Soundcloud.

    @aaronecarroll

     
    item.php